The rate cut by the ECB has led to a rise in European stocks as well as Europe-focused ETFs in the US.
The European Central Bank (ECB) lowered its benchmark interest rate on Thursday for the first time in five years due to a decrease in inflation.
Novo Nordisk A/S
Goldman Sachs predicts that Zepbound, a competitor to Eli Lilly’s Wegovy, will contribute to the growth of the weight-loss drug market to $130 billion by 2030.
Zepbound is a new weight-loss drug from Eli Lilly. According to Goldman Sachs, the anti-obesity drug market is expected to reach $130 billion by 2030, with new products like Zepbound contributing to this growth.
Eli Lilly’s Zepbound will rival Wegovy and contribute to the growth of the weight-loss drug market to reach a value of $130 billion by 2030, as predicted by Goldman Sachs.
Zepbound, Eli Lilly’s latest weight-loss medication, is projected to contribute to the growing anti-obesity drug market, which is forecasted to reach $130 billion by 2030 according to Goldman Sachs. Emerging products like Zepbound are expected to drive this market expansion.
Goldman Sachs predicts that the introduction of Zepbound, a rival of Eli Lilly’s Wegovy, will contribute to the growth of the weight-loss drug market, making it worth $130 billion by 2030.
The weight-loss drug Zepbound, developed by Eli Lilly, is a new addition to the market. Goldman Sachs predicts that the anti-obesity drug market will reach a value of $130 billion by 2030, with new products like Zepbound contributing to this growth.
Prediction suggests that a major retailer will split its stock in 2024, following in the footsteps of Walmart.
The stock market is performing exceptionally well in 2024, with both the Nasdaq Composite and S&P 500 seeing significant gains of around 11% due to strong momentum in the technology, energy, and pharmaceutical sectors.
Prediction suggests that a large retail company will split its stock in 2024, mirroring a similar move made by Walmart.
The stock market has seen strong performance in 2024, with the Nasdaq Composite and S&P 500 both rising about 11% due to positive developments in the technology, energy, and pharmaceutical sectors.
I purchased shares in Fundsmith Equity and Scottish Mortgage last year. Now I am looking to sell one of them.
The majority of my self-invested personal pension (SIPP) portfolio consists of FTSE 100 stocks, along with holdings in Scottish Mortgage Investment Trust shares and another widely recommended investment fund.
Thursday’s ETF with Unusual Volume: PID video.
The Invesco International Dividend Achievers ETF has experienced an unusually high level of trading activity in the afternoon on Thursday, with over 270,000 shares traded compared to the three-month average volume of about 137,000.
Thursday’s ETF with Unusual Volume: PID video. Read More »
